AMSP opens COVID-19 vaccines pre-orders for 55 African Union Member States
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This policy brief draws from the latest evidence on the impact of vaccination program start date and vaccine rollout rates on health benefits. The objective is to support policymakers on decisions to procure COVID-19 vaccines and roll out vaccination programmes in countries, especially those
where ...large proportions of the population remain unvaccinated.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized ...in two sections: the first section provides WHO insights on global vaccine market dynamics, drawing from data provided by Member States, which are, in turn, analysed and displayed in the second section.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                These organisations have joined forces to accelerate access to COVID-19 vaccines, therapeutics and diagnostics by leveraging multilateral finance and trade solutions, particularly for low- and middle-income countries.
The aim is to vaccinate at least 40 percent of people in every country by the end... of 2021, and at least 60 percent by mid-2022.  The effort will track, coordinate, and advance delivery of COVID-19 vaccines, therapeutics and diagnostics, working with governments and partners at the global and local levels to address finance and trade barriers to ensure that vulnerable populations have access to these life-saving tools. It supports the goals of the ACT-Accelerator and complementary initiatives.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Ce modèle de plan de communication est conçu pour donner aux pays une idée générale des activités de communication à considérer lorsqu'ils préparent l'introduction des vaccins contre la COVID-19. Le tableau ci-dessous doit être complété, avec un plan de communication narratif fournissant... des orientations et comprenant les objectifs stratégiques, les publics cibles, etc. Les pays peuvent adapter ce modèle au contexte local et y ajouter des activités en fonction du contexte national.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                17 February 2021
This article is part of a series of explainers on vaccine development and distribution. Learn more about vaccines – from how they work and how they’re made to ensuring safety and equitable access – in WHO’s Vaccines Explained series.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                MEDBOX Issue Brief no. 7, Dec. 2020
Die Impfung gegen die Ausbreitung des SARS-CoV-2-Virus stellt einen Meilenstein in der Bekämpfung der Pandemie dar. Für den Erfolg der Impfung unabdingbar ist eine gute Kommunikation und Aufklärung der Bevölkerung. Im Folgenden sind einige Informationen zur I...mpfstrategie, Durchführung der Impfung, ethische Überlegungen, sowie Aufklärungsmaterialien in deutscher und englischer Sprache aufgelistet
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This is a guidance document for countries and implementing partners on the technical requirements for developing digital information systems for issuing standards-based interoperable digital certificates for COVID-19 vaccination status, and considerations for implementation of such systems, for the ...purposes of continuity of care, and proof of vaccination.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Every country has been affected by COVID-19, with nearly a quarter 
of a billion cases and almost 5 million deaths reported globally as of 
end of September 2021. Despite the stunning speed with which highly 
effective and safe vaccines have been developed, new waves of disease 
are still pushin...g health systems to the breaking point, increasingly 
transmissible variants are emerging, some survivors are suffering 
serious long-term sequelae, and the International Monetary Fund 
estimates that global economic losses could exceed US$5.3 trillion 
by 2026, if COVID-19 becomes endemic.
Although over 6 billion doses of COVID-19 vaccine have already been 
administered, and global production is now reaching 1.5 billion doses 
per month, the world is not positioned to end the pandemic. In areas of 
high vaccine coverage, there have been massive reductions in serious 
disease, hospitalization and death but, globally, vaccine access is highly 
inequitable with coverage ranging from 1% to over 70%, depending 
largely on a country’s wealth. Consequently, SARS CoV-2 variants 
continue to emerge, causing surges of disease and slowing or even 
reversing the reopening of societies and economies.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This note builds on and is structured to align with the G...uidance on developing a national deployment and vaccination plan for COVID-19 vaccines. By providing CHW-relevant considerations for the VIRAT Tool, this document aims to support national governments in developing robust NDVPs for introducing COVID-19 vaccine(s) that leverage all the community-based deployment, implementation and monitoring tools at their disposal.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Empfehlungen des Robert Koch-Instituts für Alten- und Pflegeeinrichtungen und Einrichtungen für Menschen mit Beeinträchtigungen und Behinderungen und für den öffentlichen Gesundheitsdienst
Stand 7.4.2021
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                This inter-agency guidance document aims to supplement the COVAX demand creation package for COVID-19 vaccines with key considerations for humanitarian contexts and marginalized populations with specific access and communication needs.
21 Sept.2021
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Issue Brief no.8. January 18,2021
Vaccination against the spread of the SARS-CoV-2 virus represents a milestone in the fight against the pandemic. Good communication and education of the population is essential for the success of the vaccination. Below is some information on vaccination strategies,... implementation of the vaccination, ethical considerations, as well as educational materials in English and other languages.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the first six months of this year 85% of vaccines went to wealthy countries; lower- and middle inco...me countries have still received only a fraction of the vaccine doses they require.3 Shortages in these countries can also pose particular risks to vaccination campaigns aimed at displaced populations, as they can result in them being deprioritized.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The Country Readiness and Delivery(CRD) workstream which is part of the ACT Accelerator and is included in the SPRP– has developed a toolbox with guidance, tools and training.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Informationsseite des RKI rund um Impfen und COVID-19
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The National Deployment and Vaccination Plan for COVID-19 vaccines (NDVP): Standard Review Form (SRF) is an excel-based resource used by Regional Review Committees to assess NDVPs submitted to the Partners Platform. The SRF enables countries to prepare their NDVPs for the review process and supports... regions in conducting a consistent and uniform assessment of the submitted NDVPs. This resource should be used in conjunction with the National Deployment and Vaccination Plan for COVID-19 vaccines (NDVP): Submission and Review Process document.
                                                                    more